OUTCOME PREDICTION WITH p53 IMMUNOSTAINING AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
Authors:
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 163 (6) , 1756-1760
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomyEuropean Journal of Cancer, 1998
- Assessment of the biologic markers p53, ki‐67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgeryCancer, 1998
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- The expression of waf‐1 , p53 and bcl‐2 in prostatic adenocarcinomaBritish Journal of Urology, 1997
- Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical ProstatectomyJournal of Urology, 1996
- Quantitative microvessel density: A staging and prognostic marker for human prostatic carcinomaCancer, 1996
- Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsiesUrology, 1996
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989